+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biosurgery Market - Global Forecast 2026-2032- Product Image
Biosurgery Market - Global Forecast 2026-2032- Product Image
Sale

Biosurgery Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6082626
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biosurgery Market is projected to reach USD 20.14 Billion in 2026. It is expected to continue growing at a CAGR of 8.75%, reaching USD 33.43 Billion by 2032.

The biosurgery market sits at the intersection of surgical safety, biologic materials, and operating-room efficiency. Demand is supported by high global surgical volumes, aging populations, trauma care needs, and the steady shift toward minimally invasive and complex procedures where bleeding control, tissue sealing, adhesion prevention, and soft-tissue reinforcement are clinically important.

Market growth is shaped by the adoption of hemostatic agents, surgical sealants, adhesion barriers, bone graft substitutes, and advanced wound closure technologies. Hospitals and ambulatory surgery centers increasingly evaluate these products on measurable outcomes, including reduced blood loss, shorter procedure time, fewer complications, lower transfusion requirements, and alignment with value-based care.

Transformative Shifts in the Biosurgery Landscape

The biosurgery landscape is being transformed by three forces: procedure complexity, cost accountability, and product innovation. Surgeons are moving beyond conventional sutures, clips, and cautery when biologic or synthetic adjuncts can support faster hemostasis, more reliable tissue sealing, or reduced post-operative adhesions.

Manufacturers are responding with ready-to-use formulations, combination products, absorbable matrices, fibrin sealants, synthetic sealants, and regenerative biomaterials designed for laparoscopy, cardiovascular surgery, orthopedic surgery, neurosurgery, trauma care, and general surgery. At the same time, hospital value analysis committees are demanding stronger clinical evidence, transparent pricing, training support, and real-world performance data before adding biosurgery products to formularies.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence biosurgery through surgical planning, product selection, inventory optimization, and evidence generation. AI-enabled analytics can help hospitals identify procedure types with higher bleeding risk, forecast usage of hemostats, sealants, and adhesion barriers, and reduce waste from expired or misallocated products.

In research and development, machine learning supports biomaterial screening, protein engineering, polymer design, preclinical biocompatibility assessment, and literature-based safety signal detection. While AI does not replace surgeon judgment, it can accelerate data interpretation, strengthen post-market surveillance, and support more personalized use of biosurgical products when integrated with validated clinical workflows, cybersecurity controls, and compliant data governance.

Key Regional Insights Across Global Biosurgery

Asia-Pacific is a high-growth biosurgery region, supported by expanding surgical capacity, rising healthcare expenditure, and strong procedure volumes in China, India, Japan, South Korea, and Australia. The region benefits from public hospital expansion, private specialty care growth, local manufacturing initiatives, medical tourism, and government investments in operating-room infrastructure, which continue to widen access to hemostatic agents, surgical sealants, adhesion barriers, and regenerative surgical products.

North America remains a leading biosurgery region due to advanced hospital systems, high adoption of premium surgical technologies, mature trauma and cardiovascular care pathways, and established reimbursement mechanisms. Europe benefits from standardized clinical practice, strong surgeon training, and centralized regulatory oversight under medical device frameworks, supporting evidence-driven adoption. Latin America shows selective expansion in Brazil and Mexico, where private healthcare, specialty surgery, and tertiary hospital investment are improving access. The Middle East is investing in tertiary care centers, medical cities, and advanced surgical specialties, while Africa presents long-term opportunity as surgical access, workforce development, and hospital infrastructure improve, although affordability, procurement fragmentation, and supply-chain reliability remain key constraints.

Key Group Insights Across Biosurgery Markets

ASEAN markets are increasingly important as Indonesia, Thailand, Vietnam, Malaysia, and the Philippines invest in operating-room capacity, universal health coverage initiatives, and private healthcare networks. These developments support gradual adoption of biosurgery products in general surgery, obstetrics and gynecology, orthopedics, and trauma care. GCC countries are adopting advanced biosurgery products through specialty hospitals, national health transformation programs, and medical-city projects, particularly for cardiovascular, orthopedic, oncology-related, and emergency surgical procedures.

The European Union emphasizes safety, clinical documentation, traceability, and post-market evidence under the Medical Device Regulation, influencing product timelines, labeling, and competitive positioning. BRICS countries provide scale through large patient populations, expanding surgical infrastructure, and domestic manufacturing policies that encourage cost-sensitive product portfolios. G7 markets remain innovation-led, with strong uptake of premium surgical sealants, hemostatic agents, and absorbable matrices supported by advanced clinical pathways and value-based procurement. NATO-aligned procurement environments can strengthen demand for trauma, emergency surgery, field care, and military medical readiness applications, where fast hemostasis, portability, and dependable supply are critical.

Key Country Insights Across Biosurgery Adoption

The United States leads biosurgery adoption through advanced surgical volumes, integrated hospital networks, academic medical centers, and broad use of hemostatic and sealing products in cardiovascular, orthopedic, spine, trauma, transplant, and general surgery. Canada prioritizes evidence-based procurement and health technology assessment, while Mexico and Brazil are driven by private hospital expansion, growing specialty procedure demand, and improving access to advanced surgical consumables.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show steady biosurgery demand linked to aging populations, surgical modernization, cancer care, orthopedic procedures, and cardiovascular interventions, while Russia faces a more localized and import-sensitive supply environment. China and India are major growth engines due to large procedure volumes, healthcare infrastructure expansion, domestic manufacturing, and widening access to advanced surgical care. Japan emphasizes high-quality surgical technology, infection control, and aging-related procedure demand; South Korea supports adoption through advanced hospital infrastructure and strong surgical innovation; and Australia benefits from rigorous clinical standards, specialty care networks, and established reimbursement pathways for complex procedures.

Actionable Recommendations for Biosurgery Industry Leaders

Industry leaders should prioritize clinically differentiated biosurgery products that demonstrate faster hemostasis, reliable sealing, controlled absorption, biocompatibility, reduced adhesion risk, and ease of use in real surgical workflows. Evidence should extend beyond pivotal studies to include registry data, comparative clinical outcomes, health-economic models, and hospital-level performance metrics that support value analysis decisions.

Organizations should also localize regulatory, reimbursement, and distribution strategies by region. Partnerships with surgeons, teaching hospitals, procurement networks, emergency care programs, and digital surgery platforms can improve adoption and appropriate product use. A resilient supply chain, surgeon training programs, procedure-specific education, and AI-enabled demand forecasting will be essential to protect margins, reduce wastage, and ensure product availability across routine and emergency surgical settings.

Research Methodology for Biosurgery Insights

This executive summary is developed using a secondary and analytical research approach aligned with established market intelligence standards. Inputs include public regulatory guidance, hospital procurement trends, clinical literature on surgical hemostasis, tissue sealing, wound closure, bone regeneration, and adhesion prevention, procedure-volume indicators, healthcare infrastructure updates, and macroeconomic healthcare datasets from recognized public institutions.

Market interpretation is strengthened through triangulation across product categories, surgical specialties, end-user settings, care delivery models, and regional demand drivers. Insights are validated for consistency with known clinical practice patterns, regulatory requirements, reimbursement dynamics, and healthcare investment trends, while avoiding unsupported claims, speculative assumptions, market estimation, market sizing, market share analysis, or market forecasting.

Conclusion

Biosurgery is becoming a core component of modern operative care as hospitals pursue safer procedures, lower complication risk, better blood management, and improved resource utilization. Demand is strongest where surgical complexity, aging demographics, trauma care needs, and healthcare investment converge.

The next phase of competition will favor organizations that combine strong clinical evidence, surgeon-friendly product design, regulatory discipline, supply-chain resilience, and data-enabled commercialization. Artificial intelligence, localized market access, and measurable health-economic value will increasingly define leadership in the global biosurgery market.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Biosurgery Market, by Product Type
7.1. Introduction
7.2. Hemostats
7.3. Sealants & Adhesives
7.4. Tissue Grafts
8. Biosurgery Market, by Material Type
8.1. Introduction
8.2. Collagen-Based
8.3. Fibrin-Based
8.4. Gelatin-Based
8.5. Synthetic
9. Biosurgery Market, by Resorbability
9.1. Introduction
9.2. Nonresorbable
9.3. Resorbable
9.3.1. Fully Resorbable
9.3.2. Partially Resorbable
10. Biosurgery Market, by Application
10.1. Introduction
10.2. Cardiovascular Surgery
10.2.1. Bypass Surgery
10.2.2. Valve Repair
10.3. General Surgery
10.3.1. Hernia Repair
10.3.2. Wound Repair
10.4. Minimally Invasive Surgery
10.4.1. Endoscopic
10.4.2. Laparoscopic
10.5. Open Surgery
10.6. Orthopedic Surgery
10.6.1. Joint Replacement
10.6.2. Spinal Fusion
11. Biosurgery Market, by End User
11.1. Introduction
11.2. Ambulatory Surgery Centers
11.3. Hospitals
11.4. Specialty Clinics
11.4.1. Dental Clinics
11.4.2. Ophthalmology Clinics
12. Biosurgery Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Biosurgery Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Biosurgery Market, by Country
14.1. United States
14.2. China
14.3. Germany
14.4. United Kingdom
14.5. India
14.6. Japan
14.7. Russia
14.8. Brazil
14.9. Canada
14.10. Italy
14.11. Mexico
14.12. France
14.13. Spain
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Advanced Medical Solutions Group plc
16.2. Artivion, Inc.
16.3. B. Braun Melsungen AG
16.4. Baxter International Inc.
16.5. Becton, Dickinson and Company
16.6. BioCer Entwicklungs-GmbH
16.7. Boston Scientific Corporation
16.8. Cardinal Health, Inc.
16.9. Corza Medical GmbH
16.10. CryoLife, Inc.
16.11. CSL Limited
16.12. Hemostasis, LLC
16.13. Integra LifeSciences Holdings Corporation
16.14. Johnson & Johnson
16.15. Kuros Bioscience AG
16.16. Medtronic plc
16.17. Pfizer Inc.
16.18. RTI Surgical, Inc.
16.19. Samyang Holdings Corporation
16.20. Sanofi SA
16.21. Smith & Nephew plc
16.22. Stryker Corporation
16.23. Teleflex Incorporated
16.24. Tissue Regenix Ltd
16.25. Vivostat A/S
List of Figures
FIGURE 1. GLOBAL BIOSURGERY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BIOSURGERY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BIOSURGERY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BIOSURGERY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BIOSURGERY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BIOSURGERY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BIOSURGERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BIOSURGERY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL BIOSURGERY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BIOSURGERY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BIOSURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL HEMOSTATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL HEMOSTATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL SEALANTS & ADHESIVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL SEALANTS & ADHESIVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL SEALANTS & ADHESIVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL TISSUE GRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL TISSUE GRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL TISSUE GRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL COLLAGEN-BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL COLLAGEN-BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL COLLAGEN-BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL FIBRIN-BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL FIBRIN-BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL FIBRIN-BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL GELATIN-BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL GELATIN-BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL GELATIN-BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SYNTHETIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SYNTHETIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL SYNTHETIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL NONRESORBABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL NONRESORBABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL NONRESORBABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL RESORBABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL RESORBABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL RESORBABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL FULLY RESORBABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL FULLY RESORBABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL FULLY RESORBABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL PARTIALLY RESORBABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL PARTIALLY RESORBABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL PARTIALLY RESORBABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL BYPASS SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL BYPASS SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL BYPASS SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL VALVE REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL VALVE REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL VALVE REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL GENERAL SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL GENERAL SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL GENERAL SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL HERNIA REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL HERNIA REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL WOUND REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL WOUND REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL WOUND REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ENDOSCOPIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ENDOSCOPIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ENDOSCOPIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL LAPAROSCOPIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL LAPAROSCOPIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL LAPAROSCOPIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL OPEN SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL OPEN SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL OPEN SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL SPINAL FUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL SPINAL FUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL SPINAL FUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL DENTAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL DENTAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL DENTAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL OPHTHALMOLOGY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL OPHTHALMOLOGY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL OPHTHALMOLOGY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 108. NORTH AMERICA BIOSURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. NORTH AMERICA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 110. NORTH AMERICA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 111. NORTH AMERICA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 112. NORTH AMERICA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 113. NORTH AMERICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 114. NORTH AMERICA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 115. NORTH AMERICA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 116. NORTH AMERICA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 117. NORTH AMERICA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 120. LATIN AMERICA BIOSURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. LATIN AMERICA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 122. LATIN AMERICA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 123. LATIN AMERICA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 124. LATIN AMERICA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 125. LATIN AMERICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 126. LATIN AMERICA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 127. LATIN AMERICA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 128. LATIN AMERICA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 129. LATIN AMERICA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 130. LATIN AMERICA BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 132. EUROPE BIOSURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. EUROPE BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 134. EUROPE BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 135. EUROPE BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 136. EUROPE BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 137. EUROPE BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 138. EUROPE BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 139. EUROPE BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 140. EUROPE BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 141. EUROPE BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 142. EUROPE BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 143. EUROPE BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 144. MIDDLE EAST BIOSURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. MIDDLE EAST BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 146. MIDDLE EAST BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 147. MIDDLE EAST BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 148. MIDDLE EAST BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 149. MIDDLE EAST BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 152. MIDDLE EAST BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 153. MIDDLE EAST BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 154. MIDDLE EAST BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 155. MIDDLE EAST BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 156. AFRICA BIOSURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 157. AFRICA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 158. AFRICA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 159. AFRICA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 160. AFRICA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 161. AFRICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 162. AFRICA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 163. AFRICA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 164. AFRICA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 165. AFRICA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 166. AFRICA BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 167. AFRICA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL BIOSURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 169. ASEAN BIOSURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 170. ASEAN BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 171. ASEAN BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 172. ASEAN BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 173. ASEAN BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 174. ASEAN BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 175. ASEAN BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 176. ASEAN BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 177. ASEAN BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 178. ASEAN BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 179. ASEAN BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 180. ASEAN BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 181. GCC BIOSURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 182. GCC BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 183. GCC BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 184. GCC BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 185. GCC BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 186. GCC BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 187. GCC BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 188. GCC BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 189. GCC BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 190. GCC BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 191. GCC BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 192. GCC BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 205. BRICS BIOSURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 206. BRICS BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 207. BRICS BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 208. BRICS BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 209. BRICS BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 210. BRICS BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 211. BRICS BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 212. BRICS BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 213. BRICS BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 214. BRICS BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 215. BRICS BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 216. BRICS BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 217. G7 BIOSURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 218. G7 BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 219. G7 BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 220. G7 BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 221. G7 BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 222. G7 BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 223. G7 BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 224. G7 BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 225. G7 BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 226. G7 BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 227. G7 BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 228. G7 BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 229. NATO BIOSURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 230. NATO BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 231. NATO BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 232. NATO BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 233. NATO BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 234. NATO BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 235. NATO BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 236. NATO BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 237. NATO BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 238. NATO BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 239. NATO BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 240. NATO BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 241. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 242. UNITED STATES BIOSURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 243. UNITED STATES BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 244. UNITED STATES BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 245. UNITED STATES BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 246. UNITED STATES BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 247. UNITED STATES BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 248. UNITED STATES BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 249. UNITED STATES BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 250. UNITED STATES BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 251. UNITED STATES BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 252. UNITED STATES BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 253. UNITED STATES BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 254. CHINA BIOSURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. CHINA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 256. CHINA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 257. CHINA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 258. CHINA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 259. CHINA BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 260. CHINA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 261. CHINA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 262. CHINA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 263. CHINA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 264. CHINA BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 265. CHINA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 266. GERMANY BIOSURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 267. GERMANY BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 268. GERMANY BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 269. GERMANY BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 270. GERMANY BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 271. GERMANY BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 272. GERMANY BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 273. GERMANY BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 274. GERMANY BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 275. GERMANY BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 276. GERMANY BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 277. GERMANY BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 278. UNITED KINGDOM BIOSURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 279. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 280. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 281. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 282. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 283. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 284. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 285. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 286. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 287. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 288. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 289. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 290. INDIA BIOSURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 291. INDIA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 292. INDIA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 293. INDIA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 294. INDIA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 295. INDIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 296. INDIA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 297. INDIA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 298. INDIA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 299. INDIA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 300. INDIA BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 301. INDIA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 302. JAPAN BIOSURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 303. JAPAN BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 304. JAPAN BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 305. JAPAN BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 306. JAPAN BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 307. JAPAN BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 308. JAPAN BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 309. JAPAN BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 310. JAPAN BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 311. JAPAN BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 312. JAPAN BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 313. JAPAN BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 314. RUSSIA BIOSURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 315. RUSSIA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 316. RUSSIA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 317. RUSSIA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 318. RUSSIA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 319. RUSSIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 320. RUSSIA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 321. RUSSIA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 322. RUSSIA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 323. RUSSIA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 324. RUSSIA BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 325. RUSSIA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 326. BRAZIL BIOSURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 327. BRAZIL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 328. BRAZIL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 329. BRAZIL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 330. BRAZIL BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 331. BRAZIL BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 332. BRAZIL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 333. BRAZIL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 334. BRAZIL BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 335. BRAZIL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 336. BRAZIL BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 337. BRAZIL BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 338. CANADA BIOSURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 339. CANADA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 340. CANADA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 341. CANADA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 342. CANADA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 343. CANADA BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 344. CANADA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 345. CANADA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 346. CANADA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 347. CANADA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 348. CANADA BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 349. CANADA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 350. ITALY BIOSURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 351. ITALY BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 352. ITALY BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 353. ITALY BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 354. ITALY BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 355. ITALY BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 356. ITALY BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 357. ITALY BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 358. ITALY BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 359. ITALY BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 360. ITALY BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 361. ITALY BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 362. MEXICO BIOSURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 363. MEXICO BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 364. MEXICO BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 365. MEXICO BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 366. MEXICO BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 367. MEXICO BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 368. MEXICO BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 369. MEXICO BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 370. MEXICO BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 371. MEXICO BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 372. MEXICO BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 373. MEXICO BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 374. FRANCE BIOSURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 375. FRANCE BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 376. FRANCE BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 377. FRANCE BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2017-2032 (USD MILLION)
TABLE 378. FRANCE BIOSURGERY MARKET SIZE, BY RESORBABLE, 2017-2032 (USD MILLION)
TABLE 379. FRANCE BIOSURGERY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 380. FRANCE BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 381. FRANCE BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 382. FRANCE BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 383. FRANCE BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 384. FRANCE BIOSURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 385. FRANCE BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2017-2032 (USD MILLION)
TABLE 386. SPAIN BIOSURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 387. SPAIN BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 388.

Companies Mentioned

  • Advanced Medical Solutions Group plc
  • Artivion, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • BioCer Entwicklungs‑GmbH
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Corza Medical GmbH
  • CryoLife, Inc.
  • CSL Limited
  • Hemostasis, LLC
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Kuros Bioscience AG
  • Medtronic plc
  • Pfizer Inc.
  • RTI Surgical, Inc.
  • Samyang Holdings Corporation
  • Sanofi SA
  • Smith & Nephew plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Tissue Regenix Ltd
  • Vivostat A/S

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 20.14 Billion
Forecasted Market Value ( USD ) by 2032 $ 33.43 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Biosurgery Market Report by Product, Source, Application, End User, and Region 2026-2034 - Product Image

Biosurgery Market Report by Product, Source, Application, End User, and Region 2026-2034

  • Report
  • 148 Pages
  • Global
From
Biosurgery Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Application, End User, Material - Product Image

Biosurgery Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Application, End User, Material

  • Report
  • 160 Pages
  • Global
From
Biosurgery - Global Strategic Business Report - Product Image

Biosurgery - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Biosurgery Market Report 2026 - Product Image

Biosurgery Market Report 2026

  • Report
  • 250 Pages
  • Global
From
UAE Biosurgery Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Image

UAE Biosurgery Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • 94 Pages
  • United Arab Emirates United Arab Emirates
From

About the Biosurgery Market

Biosurgery is a rapidly growing field of medical technology that focuses on the use of biological materials to repair, replace, or supplement damaged or missing tissue. It is used in a variety of surgical procedures, including reconstructive surgery, orthopedic surgery, and plastic surgery. Biosurgery products are designed to provide a more natural and effective solution to tissue repair and regeneration. These products are often made from biocompatible materials, such as collagen, hyaluronic acid, and other proteins, and are designed to be minimally invasive and to reduce the risk of infection. Biosurgery products are used in a variety of surgical procedures, including wound healing, tissue engineering, and regenerative medicine. They are also used to treat a variety of conditions, such as burns, ulcers, and hernias. Biosurgery products are also used in cosmetic surgery, such as breast augmentation and facial reconstruction. Some of the companies in the biosurgery market include Allergan, Baxter, Bausch Health, Covidien, Johnson & Johnson, Medtronic, and Smith & Nephew. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.